medmix AG
medmix's GHG Emissions Data Preview
In 2024, medmix completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, medmix has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind medmix’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore medmix’s data sources below and access millions more through our Disclosure Search.
Insights into medmix's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of medmix amounted to 10,231 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of medmix increased by 82.86%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
medmix's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are medmix's Scope 1 emissions?
In 2024, the total Scope 1 emissions of medmix were 4,351 metric tons of CO₂ equivalent (tCO₂e). a
Has medmix reduced its Scope 1 emissions over time?
Since 2022, medmix's Scope 1 emissions have decreased by 19.55%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), medmix's Scope 1 emissions remained relatively stable, indicating that medmix's emissions have plateaued with no significant change in its operational footprint. a
What are medmix's Scope 2 emissions?
In 2024, medmix reported Scope 2 greenhouse gas (GHG) emissions of 5,880 tCO₂e using the market-based method. a
Has medmix reduced its Scope 2 emissions over time?
Since 2022, medmix's Scope 2 greenhouse gas (GHG) emissions ( Market-Based) have increased by 280.58%, reflecting a rising long-term trend in Scope 2 emissions over time. a
Compared to the previous year (2023), medmix's Scope 2 emissions (Market-Based) rose by 384.35% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does medmix use for Scope 2 reporting?
In 2024, medmix reported its Scope 2 emissions using the market-based method. a
medmix's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based
Insights into medmix's Value Chain Emissions
In 2024, medmix reported 58,000 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of medmix includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
medmix's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are medmix's Scope 3 emissions?
In 2024, medmix reported total Scope 3 emissions of 58,000 metric tons of CO₂ equivalent (tCO₂e). a
Has medmix reduced its Scope 3 emissions over time?
Since 2022, medmix's Scope 3 emissions have remained relatively stable, indicating that medmix 's emissions have plateaued with no significant change in its value chain footprint. a
Compared to the previous year (2023), medmix's Scope 3 emissions remained relatively stable, indicating that medmix 's emissions have plateaued with no significant change in its value chain footprint. a
Insights into medmix’s GHG Emissions Intensity Compared to Industry Peers
In 2024, medmix reported Scope 1 greenhouse gas (GHG) emissions of 4,351 tCO₂e and total revenues of USD 534 millions. This translates into an emissions intensity of 8.14 tCO₂e per millions USD. a
medmix's Scope 1 Emissions Intensity Compared to Peers
How does medmix's GHG emissions intensity compare to its peers?
In 2024, medmix reported a Scope 1 emissions intensity of 8.14 tCO₂e per millions USD. Compared to the peer group median of 7.28 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does medmix rank on GHG emissions intensity within its industry?
In 2024, medmix ranked 15 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
medmix is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into medmix's Total Carbon Footprint
In 2024, medmix reported a total carbon footprint of 68,231 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 10.7% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to medmix's total carbon footprint was Scope 3 emissions, accounting for 85.01% of the company's total carbon footprint, followed by Scope 2 emissions at 8.62%. a